CIBCX
Price
$73.14
Change
+$0.78 (+1.08%)
Updated
May 2 closing price
Net Assets
109.11B
FFACX
Price
$15.74
Change
+$0.12 (+0.77%)
Updated
May 2 closing price
Net Assets
2.64B
Ad is loading...

CIBCX vs FFACX

Header iconCIBCX vs FFACX Comparison
Open Charts CIBCX vs FFACXBanner chart's image
American Funds Capital Income Bldr C
Price$73.14
Change+$0.78 (+1.08%)
VolumeN/A
Net Assets109.11B
Franklin Global Allocation C
Price$15.74
Change+$0.12 (+0.77%)
VolumeN/A
Net Assets2.64B
CIBCX vs FFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIBCX vs. FFACX commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIBCX is a Buy and FFACX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CIBCX has more cash in the bank: 109B vs. FFACX (2.64B). CIBCX pays higher dividends than FFACX: CIBCX (2.40) vs FFACX (0.39). CIBCX was incepted earlier than FFACX: CIBCX (24 years) vs FFACX (22 years). FFACX (1.75) is less costly to investors than CIBCX (1.34). FFACX is a more actively managed with annual turnover of: 59.82 vs. CIBCX (56.00). CIBCX has a lower initial minimum investment than FFACX: CIBCX (250) vs FFACX (1000). CIBCX annual gain was more profitable for investors over the last year : 12.21 vs. FFACX (9.06). CIBCX return over 5 years is better than : 45.89 vs. FFACX (42.32).
CIBCXFFACXCIBCX / FFACX
Total Expense Ratio1.341.7278%
Annual Report Gross Expense Ratio1.341.7577%
Fund Existence24 years22 years-
Gain YTD6.1270.904677%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets109B2.64B4,126%
Annual Yield % from dividends2.400.39615%
Returns for 1 year12.219.06135%
Returns for 3 years17.6817.8999%
Returns for 5 years45.8942.32108%
Returns for 10 years35.0226.38133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUECX31.330.48
+1.56%
MFS Blended Research Core Equity C
ALABX11.88N/A
N/A
ALPS/Smith Balanced Opportunity A
FCNSX16.68N/A
N/A
Fidelity Series Canada
FMEFX36.99N/A
N/A
Nuveen Small/Mid Cap Growth Opp R6
SCAVX12.79N/A
N/A
AB Small Cap Value A